$NVVE Cashflow Statement | Understand Stock

$NVVE

$3.23 +$0.00 (0.0%) Close

$NVVE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile to net loss to net cash used in operating activities
Depreciation and amortization
Share-based compensation
Financing costs
Beneficial conversion feature on convertible debenture
Convertible note issued for services
Accretion of discount on convertible notes
Inventory impairment loss
Change in fair value of warrants liability
Change in fair value of convertible notes
Change in fair value of derivative liability
Fair value of warrants issued for cryptocurrency strategy consulting services
Loss on warrants issuance
Loss on disposal of asset
Gain on extinguishment of PPP Loan
Interest expense related to notes converted at discount
Provision for credit losses
Amortization of discount on debt and promissory notes
Gains from the sale of equity investment interest
Noncash lease expense
Change in operating assets and liabilities
Accounts receivable
Inventory
Prepaid expenses and other assets
Accounts payable
Advance deposit from customer
Accrued expenses and other liabilities
Deferred revenue

Net cash used in operating activities
Investing activities
Proceeds from sale of property and equipment
Cash used in acquisition
Purchase of property and equipment
Investments in equity securities
Proceeds from sale of equity investment interest
Net cash provided by (used in) investing activities

Financing activities
Proceeds from issuance of convertible debenture
Proceeds from issuance of convertible notes
Proceeds from Newborn Escrow Account
Redemption of Newborn shares
Issuance costs related to reverse recapitalization and PIPE offering
Proceeds from PIPE offering
Repayment of Newborn sponsor loans
Newborn cash acquired
Purchase of stock from investor
Payment of financing costs
Proceeds from debt and promissory notes obligations, net of issuance costs
Repayment of debt and promissory notes obligations
Payment of finance lease obligations
Proceeds from PPP/EIDL Loan
Repayment of EIDL Loan
Proceeds from forward option put exercise
Proceeds from issuance of Class B units
Proceeds from exercise of warrants
Proceeds from Direct Offering of common stock, net of offering costs
Proceeds from convertible series A preferred, net of offering costs
Proceeds from common stock offering, including pre-funded warrants, net of offering costs
Proceeds from exercise of stock options
Issuance Costs Related to Preferred Stock
Issuance of Redeemable Preferred Stock
Payment of Preferred Stock dividends
Proceeds from shareholder loan
Repayment proceeds from shareholder loan
Proceeds from issuance of series 3 J-Kiss units
Net cash provided by financing activities

Effect of exchange rate on cash
Net decrease in cash and restricted cash
Cash and restricted cash at beginning of year
Cash and restricted cash at end of year
Supplemental Disclosure of cash information:
Cash paid for interest
Cash paid for income taxes
Supplemental Disclosure of Noncash Investing and Financing Activities:
Convertible notes issued in exchange for deferred salary liability to an officer
Issuance of convertible notes for services
Conversion option issued
Conversion of preferred stock to common stock
Transfer of inventory to property and equipment
Conversion of Notes and accrued interest to common shares
Conversion of shares due to reverse recapitalization
Beneficial conversion feature
Issuance of common stock for merger success fee
Accrued transaction costs related to reverse recapitalization
Issuance of private warrants
Forgiveness of PPP Loan
Issuance of Stonepeak and Evolve warrants
Issuance of Stonepeak and Evolve options
Payment of Promissory with Receivable
Issuance of preferred class A units for acquisition
Issuance of common shares in exchange for payment of promissory note
Issuance of Series 3 J-Kiss units in exchange for loan receivable

Comments